Differential expression of VEGFR2 protein in HER2 positive primary human breast cancer: potential relevance to anti-angiogenic therapies
Crossref DOI link: https://doi.org/10.1186/S12935-017-0427-5
Published: 2017-12
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Nasir, Aejaz http://orcid.org/0000-0001-7254-1568
Holzer, Timothy R.
Chen, Mia
Man, Michael Z.
Schade, Andrew E.
Funding for this research was provided by:
Eli Lilly & Co